Skip to main content

Find Clinical Trials

Home
Conditions
Neurobehavioral Manifestations

Clinical trial condition

Neurobehavioral Manifestations

Explore clinical trials studying Neurobehavioral Manifestations. Study availability and eligibility vary by location and protocol.

102 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Neurobehavioral Manifestations trial results

Completed

NiPPeR Randomised Trial - Child Follow Up Study

NCT05934422

Conditions: Allergy, Atopic Dermatitis, Atopy, +38 more
Locations: The University of Auckland Auckland, New Zealand

National University Hospital Singapore

University Hospital Southampton Southampton, Hampshire, United Kingdom

View Trial Details

Completed

Safety and Efficacy of Sequential Therapy With Mexidol® in Patients With Chronic Cerebral Ischemia

NCT06834490

Conditions: Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +18 more
Locations: Municipal Autonomous Healthcare Insitution of the Order of the Red Banner of Labour "City Clinical Hospital No.1" Chelyabinsk, Russia

Regional Budget Healthcare Institution "Ivanovo Regional Clinical Hospital" Ivanovo, Russia

Federal State Budget Educational Institution of Higher Education "Kazan State Medical University" Kazan', Russia

Federal State Budget Research Institution "Research Center of Neurology" Moscow, Russia

View all 14 locations

View Trial Details

Completed

Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19

NCT04809974

Conditions: COVID-19, Chronic Disease, Cognitive Symptom, +22 more
Locations: Clinical Translational Research Unit Boston, Massachusetts, United States

View Trial Details

Completed

Integral Cognitive Remediation for Depression

NCT07014683

Conditions: Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder (MDD), +7 more
Locations: Institut de Recerca Sant Pau- Mental Health Group Barcelona, Catalonia, Spain

View Trial Details

Completed

Neural Biomarkers in Fragile X Syndrome

NCT06957054

Conditions: Central Nervous System Diseases, Chromosome Disorders, Congenital Abnormalities, +20 more
Locations: Hospital del Mar Research Institute (HMRI) Barcelona, Spain

Consorci Corporació Sanitaria Parc Taulí. Institut Investigació i Innovació Parc Taulí (I3PT) Sabadell, Barcelona, Spain

View Trial Details

Completed

CTH120 First-in-Human Study: Single and Multiple Ascending Doses and Potential Food Interaction

NCT06480968

Conditions: Central Nervous System Diseases, Chromosome Disorders, Congenital Abnormalities, +18 more
Locations: Hospital del Mar Medical Research Institute (IMIM) Barcelona, Spain

View Trial Details

Completed

A Trial of Metformin in Individuals With Fragile X Syndrome

NCT03479476

Conditions: Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +19 more
Locations: UC Davis MIND Institute Sacramento, California, United States

University of Alberta Edmonton, Alberta, Canada

St Justine Hospital Montreal, Quebec, Canada

View Trial Details

Completed

Dopaminergic Therapy for Frontotemporal Dementia Patients

NCT04937452

Conditions: Aphasia, Aphasia, Primary Progressive, Brain Diseases, +22 more
Locations: Giacomo Koch Rome, <None>, Italy

Department of Neurology, University of Brescia Brescia, Italy

Santa Lucia Foundation Rome, Italy

View Trial Details

Completed

Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome

NCT05657860

Conditions: Aberrant Motor Behavior in Dementia, Abnormalities, Multiple, Aggression, +34 more
Locations: Maimonides Medical Center Brooklyn, New York, United States

View Trial Details

Completed

Chronic Neck Pain and Cognitive Function

NCT06504004

Conditions: Cognitive Symptom, Neck Pain, Nervous System Diseases, +5 more
Locations: School of Sarıkaya Physical Therapy and Rehabilitation Yozgat, Turkey (Türkiye)

View Trial Details